Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 902219 Boston, MA

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,731,613
+$6,137,762 QoQ
Shares Held
2,365,103
+8.9% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 236 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 68% None 32%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 XERS
Xeris Biopharma Holdings, Inc.
This page
2,365,103 $18,731,613

All Filings in XERS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,731,613 2,365,103
2026-03-31 $12,593,851 2,171,354
2025-12-31 $17,949,792 2,286,598
2025-09-30 $4,729,029 580,962
2025-06-30 $1,864,688 399,291
2025-03-31 $2,152,623 392,099
2024-12-31 $1,576,728 465,112
2024-09-30 $1,344,184 471,644
2024-06-30 $949,744 422,109
2024-03-31 $877,247 396,945